NYSE
FPCG
Last Price
US $1025.00
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Avem Health Partners, Inc. balance-sheet data unavailable; cash-flow debt coverage cannot be computed.
Financial risk - Healthy cash flow growth.
Avem Health Partners, Inc. has insufficient data to evaluate this check.
Financial risk - Healthy debt to equity ratio.
Avem Health Partners, Inc. has insufficient data to evaluate this check.
Financial risk - Healthy debt to equity ratio development.
Avem Health Partners, Inc. has insufficient data to evaluate this check.
Financial risk - Net debt/EBITDA.
Avem Health Partners, Inc. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Avem Health Partners, Inc. interest expense data unavailable for the most recent period; interest coverage ratio cannot be reliably computed.
Financial risk - Profit margin growth.
Avem Health Partners, Inc.'s profit margin has decreased (-14.19%) in the last year from 34.69% to 29.77%, signaling decreasing performance
Financial risk - Short term assets vs short term liabilities.
Avem Health Partners, Inc. has insufficient data to evaluate this check.
Decreasing performance - ROA.
Avem Health Partners, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Avem Health Partners, Inc.'s return on equity of 0.00%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Avem Health Partners, Inc. has insufficient data to evaluate this check.
Decreasing performance - Earnings stability.
Avem Health Partners, Inc. had positive net income in only 2.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Avem Health Partners, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Avem Health Partners, Inc. has a free cash flow yield of 0.00%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Increasing performance - Healthy earnings growth.
Avem Health Partners, Inc.'s yearly earnings has increased 2.76% since last year from $5.62M to $5.77M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Avem Health Partners, Inc.'s yearly revenue has increased 19.75% since last year from $16.19M to $19.39M, signaling increasing performance
Decreasing performance - ROIC.
ROIC 0.00% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Avem Health Partners, Inc.'s 3-year revenue CAGR of -21.11% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Avem Health Partners, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Avem Health Partners, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Avem Health Partners, Inc. has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Avem Health Partners, Inc. has an earnings yield of 74.86%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Avem Health Partners, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Avem Health Partners, Inc. has an EV/EBITDA ratio of 1.56x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Avem Health Partners, Inc. has a PEG-ratio under 1 which is considered undervalued
Overvalued - P/B ratio.
Avem Health Partners, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
Avem Health Partners, Inc. has a price-to-sales ratio of 0.40x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-
Return on equity
ROIC: -
Valuation History
-
Price to Earnings
EV/EBITDA: -
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $1025.00
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.